# MS-Metagenomes
This study investigated gut microbiome alterations in Multiple Sclerosis (MS) by analyzing fecal samples from treatment-na√Øve and ocrelizumab-treated patients across two German centers. Using metagenomic sequencing and matched controls, it aimed to reduce confounders of previous studies and identify disease-specific microbial changes.
